NEW YORK (GenomeWeb News) – NanoInk today said it has won a $735,000 Phase II Small Business Innovation Research grant from the National Human Genome Research Institute to develop "nanostructures” that can “enhance the reproducibility, sensitivity, and spatial density of chip-based assays.”